Liberia vs Zimbabwe: Population requiring preventive chemotherapy for schistosomiasis
Liberia
2.49 million
in 2024
Zimbabwe
2.71 million
in 2024
Liberia rank
28th
Zimbabwe rank
27th
Population requiring preventive chemotherapy for schistosomiasis over time
- Liberia
- Zimbabwe
How they compare
Zimbabwe currently reports 2.71 million against 2.49 million in Liberia, a difference of 222,360.
That makes Zimbabwe's figure about 1.1 times Liberia's.
Across all 15 years both countries report, Zimbabwe has been ahead every year.
Liberia ranks 28th and Zimbabwe ranks 27th of 52 countries.
Zimbabwe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.12 million | 3.52 million | 2.40 million | Zimbabwe |
| 2020s | 1.42 million | 2.82 million | 1.40 million | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Liberia or Zimbabwe?
- Zimbabwe, at 2.71 million against 2.49 million in Liberia as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Liberia and Zimbabwe?
- 222,360, with Zimbabwe ahead.
- How many years of comparable data are there for Liberia and Zimbabwe?
- 15 years are reported by both, from 2010 to 2024.
- How do Liberia and Zimbabwe rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Liberia ranks 28th and Zimbabwe ranks 27th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.